Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DARE - Dare Bioscience GAAP EPS of $0.00 revenue of $10M

DARE - Dare Bioscience GAAP EPS of $0.00 revenue of $10M

Dare Bioscience Inc.
  • Dare Bioscience press release ( NASDAQ: DARE ): Q2 GAAP EPS of $0.00.
  • Revenue of $10M.
  • License fee revenue recognition: $10.0 million during 2Q-2022 in connection with the closing under the global license agreement with Organon to commercialize XACIATO
  • Upon the first commercial sale of XACIATO, currently expected in 4Q-2022, we may receive another $2.5 million in license fee revenue.
  • Cash and cash equivalents: $32.1 million at June 30, 2022, compared to $51.7 million at December 31, 2021.

For further details see:

Dare Bioscience GAAP EPS of $0.00, revenue of $10M
Stock Information
Company Name: Dare Bioscience Inc.
Stock Symbol: DARE
Market: NASDAQ
Website: darebioscience.com
Menu
DARE DARE Quote DARE Short DARE News DARE Articles DARE Message Board
Get DARE Alerts

News, Short Squeeze, Breakout and More Instantly...